Louis Dreyfus Family Office LLC Celularity Inc Put Options Transaction History

Louis Dreyfus Family Office LLC

  • $64.7 Million
  • Q3 2022

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $325M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Louis Dreyfus Family Office LLC Portfolio

Follow Louis Dreyfus Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louis Dreyfus Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Louis Dreyfus Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email